Dimensional Fund Advisors LP Cuts Stock Position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)

Dimensional Fund Advisors LP cut its holdings in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 272,969 shares of the specialty pharmaceutical company’s stock after selling 11,036 shares during the quarter. Dimensional Fund Advisors LP owned 1.94% of Cumberland Pharmaceuticals worth $647,000 at the end of the most recent quarter.

Cumberland Pharmaceuticals Stock Performance

CPIX stock opened at $4.71 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.99. The business has a 50-day moving average price of $4.64 and a 200 day moving average price of $3.43. The company has a market capitalization of $70.47 million, a P/E ratio of -6.12 and a beta of -0.35. Cumberland Pharmaceuticals Inc. has a 1-year low of $1.04 and a 1-year high of $7.25.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last released its quarterly earnings data on Tuesday, May 6th. The specialty pharmaceutical company reported $0.15 earnings per share for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 9.50% and a negative net margin of 29.54%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Cumberland Pharmaceuticals from a “buy” rating to a “strong-buy” rating in a research report on Thursday, May 8th.

Cumberland Pharmaceuticals Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.